Corey Fishman, CEO of Iterum, expressed pride in achieving this FDA approval, emphasizing the drug’s potential to offer new hope for patients dealing with difficult-to-treat infections. The ...
This is the first approved indication for Orlynvah and the first FDA-approved product for Iterum. "We are so pleased to have achieved this historic milestone and would like to thank all the patients, ...
The clinical-stage pharmaceutical company said Friday that the Food and Drug Administration has approved its new drug application for Orlynvah as a treatment for uncomplicated urinary tract infections ...